<?xml version="1.0"?>
<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule">
	<channel>
		<title>Medscape Hematology-Oncology Headlines</title>
		<link>http://www.medscape.com/hematology-oncology?src=rss</link>
		<description>Latest medical news, articles, and features from Medscape Hematology-Oncology</description>
		<image>
			<url>http://images.medscape.com/pi/global/logos/mscp/logo-medscape110x30.gif</url>
			<title>Medscape Hematology-Oncology Headlines</title>
			<link>http://www.medscape.com/hematology-oncology?src=rss</link>
		</image>
		<language>en-us</language>
		<copyright>Copyright 2008, Medscape</copyright>
		<pubDate>Sat, 11 Oct 2008 10:05:17 EDT</pubDate>
		<managingEditor>HemOnceditor@medscape.net</managingEditor>
		<webMaster>medscapecustomersupport@webmd.net (Medscape Customer Support)</webMaster>

		<item>
			<title>Why and How to Use the Photographic Atlases of the American Registry of Pathology</title>
			<link>http://www.medscape.com/viewarticle/581398?src=rss</link>
			<description>William A. Gardner, MD, Executive Director, American Registry of Pathology, Silver Spring, Maryland, describes the importance of visual images to medicine. 
  &lt;br /&gt; &lt;i&gt;The Medscape Journal of Medicine&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Fri, 10 Oct 2008 08:43:16 EDT</pubDate>
		</item>
		<item>
			<title>More Targeted Cancer Therapies Set to Become &quot;Blockbusters&quot;</title>
			<link>http://www.medscape.com/viewarticle/581868?src=rss</link>
			<description>Targeted cancer therapeutics have become best-selling products and are driving overall growth in the oncology pharmaceutical market.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Fri, 10 Oct 2008 11:04:11 EDT</pubDate>
		</item>
		<item>
			<title>Political Issues Affect Cancer Care as US Election Looms</title>
			<link>http://www.medscape.com/viewarticle/581876?src=rss</link>
			<description>Although the current financial crisis has overshadowed healthcare reform, cancer care remains on the radar of both presidential candidates.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Fri, 10 Oct 2008 13:21:00 EDT</pubDate>
		</item>
		<item>
			<title>Talc Use in Genital Area Linked to Increased Risk for Ovarian Cancer</title>
			<link>http://www.medscape.com/viewarticle/581862?src=rss</link>
			<description>Women should avoid using talc in the genital area, say researchers reporting further evidence supporting an association between such use and an increase in the risk for ovarian cancer.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Fri, 10 Oct 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Overweight, High C-Peptide May Predict Future Mortality From Prostate Cancer</title>
			<link>http://www.medscape.com/viewarticle/581860?src=rss</link>
			<description>Both excess body weight and a high plasma concentration of C-peptide predispose men with a subsequent diagnosis of prostate cancer to an increased likelihood of dying of this disease.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Urology</category>
					<pubDate>Fri, 10 Oct 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Optimal Chelation Techniques for Transfusion-Related Iron Overload in Patients With Myelodysplastic Syndrome</title>
			<link>http://www.medscape.com/viewprogram/17457?src=rss</link>
			<description>In this expert column, Dr. Elias Jabbour and Dr. Hagop Kantarjian discuss adverse effects associated with iron overload in patients with MDS and the role of chelation therapy in improving patient outcomes.  &lt;br /&gt; &lt;i&gt;Medscape Hematology-Oncology&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Thu, 9 Oct 2008 12:00:00 EDT</pubDate>
		</item>
		<item>
			<title>DNA Stool Tests Show Promise for Colorectal Cancer Screening</title>
			<link>http://www.medscape.com/viewarticle/581808?src=rss</link>
			<description>A second-generation stool DNA test proved to be more sensitive in detecting malignant and premalignant lesions than widely used fecal occult blood tests.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Thu, 9 Oct 2008 08:15:00 EDT</pubDate>
		</item>
		<item>
			<title>Assisted-Suicide Law May Not Adequately Protect Depressed Patients</title>
			<link>http://www.medscape.com/viewarticle/581828?src=rss</link>
			<description>New research is raising concerns that assisted-suicide laws may not adequately protect terminally ill individuals who have comorbid clinical depression.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Psychiatry</category>
					<pubDate>Thu, 9 Oct 2008 12:59:00 EDT</pubDate>
		</item>
		<item>
			<title>New Recommendations Provide Age for Stopping Colorectal Screening</title>
			<link>http://www.medscape.com/viewarticle/581804?src=rss</link>
			<description>For the first time, new recommendations from the US Preventive Services Task Force provide an age for stopping colorectal screening; new guidance on the use of fecal occult blood tests is available.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Thu, 9 Oct 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Tamoxifen May Allow Earlier Detection of ER-Negative Breast Cancer</title>
			<link>http://www.medscape.com/viewarticle/581777?src=rss</link>
			<description>Tamoxifen chemoprevention is already known to reduce ER-positive breast cancer, but a new study suggests it might also speed up the diagnosis of ER-negative tumors.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Wed, 8 Oct 2008 15:09:00 EDT</pubDate>
		</item>
		<item>
			<title>Talc Use in Genital Area Linked to Increased Risk for Ovarian Cancer</title>
			<link>http://www.medscape.com/viewarticle/581781?src=rss</link>
			<description>Women should avoid using talc in the genital area, say researchers reporting evidence supporting the association between such use and an increase in the risk for ovarian cancer.   &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Wed, 8 Oct 2008 15:50:27 EDT</pubDate>
		</item>
		<item>
			<title>FDA Approvals: Reyataz and Alimta</title>
			<link>http://www.medscape.com/viewarticle/581746?src=rss</link>
			<description>The FDA has approved expanded indications for atazanavir sulfate capsules (Reyataz) and pemetrexed injection (Alimta).  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pharmacist</category>
					<pubDate>Wed, 8 Oct 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Advances in the Management of Metastatic Breast Cancer: Hormonal Therapy and Targeted Agents</title>
			<link>http://www.medscape.com/viewprogram/17377?src=rss</link>
			<description>A review of hormonal therapy options for postmenopausal patients with advanced hormone receptor-positive breast cancer.  &lt;br /&gt; </description>
			<category>Hematology-Oncology</category>
					<pubDate>Tue, 7 Oct 2008 12:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Pemetrexed Plus Cisplatin Has &quot;Remarkable&quot; Results in Mesothelioma</title>
			<link>http://www.medscape.com/viewarticle/581672?src=rss</link>
			<description>Results of 2 phase 3 trials indicate that combination therapy significantly prolongs survival in mesothelioma.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pulmonary Medicine</category>
					<pubDate>Tue, 7 Oct 2008 08:57:03 EDT</pubDate>
		</item>
		<item>
			<title>Surgery for Colorectal Metastases to Peritoneum is an Option, Says Study</title>
			<link>http://www.medscape.com/viewarticle/581688?src=rss</link>
			<description>A surgical approach to peritoneal surface disease, when successful, can have outcomes comparable to the resection of colorectal hepatic metastases.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Tue, 7 Oct 2008 12:00:11 EDT</pubDate>
		</item>
		<item>
			<title>First-Line Chemo for Small-Cell Lung Cancer is Not Superior to Second-Line</title>
			<link>http://www.medscape.com/viewarticle/581676?src=rss</link>
			<description>A meta-analysis has found that platinum-based regimens do not offer significant benefit in survival or overall tumor response, compared with second-line nonplatinum-based regimens.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Tue, 7 Oct 2008 18:58:32 EDT</pubDate>
		</item>
		<item>
			<title>New Finding May Improve Diagnosis of Juvenile Leukemia</title>
			<link>http://www.medscape.com/viewarticle/581586?src=rss</link>
			<description>An abnormal signaling pathway that appears to be highly specific to juvenile myelomonocytic leukemia could allow for more rapid and accurate diagnosis and targeted therapies.   &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Mon, 6 Oct 2008 12:59:56 EDT</pubDate>
		</item>
		<item>
			<title>Scientists Discover Neuroblastoma Gene</title>
			<link>http://www.medscape.com/viewarticle/580334?src=rss</link>
			<description>The author discusses new findings about a genetic cause of neuroblastoma. 
  &lt;br /&gt; &lt;i&gt;Medscape Genomic Medicine&lt;/i&gt;</description>
			<category>Pathology &amp; Lab Medicine</category>
					<pubDate>Mon, 6 Oct 2008 13:39:00 EDT</pubDate>
		</item>
		<item>
			<title>Black Patients Have Poorer Survival in Head and Neck Cancer</title>
			<link>http://www.medscape.com/viewarticle/581593?src=rss</link>
			<description>A new analysis shows that race and socioeconomic status have a significant affect on patient survival in head and neck cancer, even after adjustment for other factors  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Mon, 6 Oct 2008 14:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Let&apos;s Not Give Up on Dual Antibodies in Colon Cancer...Yet</title>
			<link>http://www.medscape.com/viewarticle/581472?src=rss</link>
			<description>In this video blog, Dr. John Marshall observes that despite unexpected negative results in the PACCE and CAIRO2 trials, dual antibody therapy may yet play a role in colorectal cancer. 
  &lt;br /&gt; &lt;i&gt;Medscape Hematology-Oncology&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Sat, 4 Oct 2008 22:28:35 EDT</pubDate>
		</item>

</channel>
</rss>